Renoprotective effect of erythropoietin against ischaemiareperfusion injury in a non-human primate model

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1157-1162

  Ishii, Yasuo ^a   Sawada, Tokihiko ^b   Murakami, Toru ^a   Sakuraoka, Yuhki ^b   Shiraki, Takayuki ^b   Shimizu, Akira ^c   Kubota, Keiichi ^b   Fuchinoue, Shohei ^a   Teraoka, Satoshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

erythropoietin; ischaemia perfusion injury; kidney; monkey

Indexed keywords

CREATININE; CYSTATIN C; ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 6; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL PROTECTION; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; APOPTOSIS; CREATININE; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HUMANS; KIDNEY FUNCTION TESTS; MACACA FASCICULARIS; MALE; MONKEY DISEASES; REPERFUSION INJURY;

EID: 79953836166     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq601     Document Type: Article

References (38)

1. Liaño F, Junco E, Pascual J et al. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int 1998; 53: S16-S24
2. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936 (Pubitemid 34454211)
3. Boros P, Bromberg JS. New cellular and molecular pathways in ischemia/reperfusion injury. Am J Transplant 2006; 6: 652-658 (Pubitemid 43345001)
4. Heyman S, Khamaisi M, Rosen S et al. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 2008; 28: 998-1006
5. Zanjani ED, Poster J, Burlington H et al. Liver as the primary site of erythropoietin formation in the fetus. J Lab Clin Med 1977; 89: 640-644 (Pubitemid 8082916)
6. Jacobson LO, Goldwasser E, Freid W et al. Role of the kidney in erythropoiesis. Nature 1957; 179: 633-634
7. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993; 90: 4304-4308 (Pubitemid 23134215)
8. Semenza GL, Mkl N, Chi SM et al. Hypoxia-inducible nuclear factors binds to an enhancer element located 3' to the human erythro-poietin gene. Proc Natl Acad Sci USA 1991; 88: 5680-5684 (Pubitemid 21914809)
9. Paliege A, Rosenberger C, Bondke A et al. Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int 2010; 77: 312-318
10. Arcasoy MO. The non-haematopoietic biological effects of erythro-poietin. Br J Haematol 2008; 141: 14-31
11. Yang CW, Li C, Jung JY et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003; 17: 1754-1755
12. Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney. Kidney Int 2004; 66: 983-989 (Pubitemid 39121002)
13. Sharples E, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2240-2241
14. Vaziri ND, Zhou XJ, Liao SY. Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am J Physiol 1994; 266: F360-F366
15. Okada T, Sawada T, Kubota K. Asialoerythropoietin has strong reno-protective effects against ischemia-reperfusion injury in a murine model. Transplantation 2007; 84: 504-510 (Pubitemid 47312162)
16. Song YR, Lee T, You SJ et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009; 30: 253-260
17. Goldfarb M, Rosenberger C, Ahuva S et al. A role for erythropoietin in the attenuation of radiocontrast-induced acute renal failure in rat. Ren Fail 2006; 28: 345-350 (Pubitemid 43977346)
18. Yokomaku Y, Sugimoto T, Kume S et al. Asialoerythropoietin prevents contrast-induced nephropathy. J Am Soc Nephrol 2008; 19: 321-328 (Pubitemid 351246572)
19. Vesey DA, Cheung C, Pat B et al. Erythropoietin protects against ischemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-355 (Pubitemid 38195983)
20. Gong H, Wang W, Kwon TH et al. Erythropoietin and α-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 2004; 66: 683-695 (Pubitemid 38982012)
21. Ehrenreich H, Hasselblatt M, Dembowski C et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8: 495-505 (Pubitemid 36337492)
22. Ehrenreich H, Hinze-Selch D, Stawicki S et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 2007; 12: 206-220 (Pubitemid 46160985)
23. Lipsic E, van der Meer P, Voors AA et al. A single bolus of a long-acting erythropoietin analogue darbepoetin α in patients with acute myocardial infarction. A randomized feasibility and safety study. Cardiovasc Drugs Ther 2006; 20: 135-141 (Pubitemid 43876097)
24. Belonje AM, Voors AA, van Gilst WH et al. Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III). Am Heart J 2008; 155: 17-22
25. Mocini D, Muso P, Guendouz E et al. Endogenous erythropoietin and single bolus of 40, 000 IU of epoetin alpha do not protect the heart from ischemia-reperfusion injury during extracorporeal circulation for cardiac surgery. Perfusion 2008; 23: 187-192
26. D'Andrea AD, Lodish HF, Wong GG. Expression cloning of the mur-ine erythropoietin receptor. Cell 1989; 57: 277-285 (Pubitemid 19112366)
27. Brines M, Grasso G, Fiordaliso F et al. Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit hetero-receptor. Proc Natl Acad Sci USA 2004; 101: 14907-14912 (Pubitemid 39410773)
28. Witthuhn B, Quelle FW, Silvennoinen O et al. JAK2 associates with the erythropoietin receptor and its tyrosine phosphorylated and activated following stimulation with Erythropoietin. Cell 1996; 74: 227-236 (Pubitemid 23221699)
29. Damen JE, Wakao H, Miyajima A et al. Tyrosine 343 in the erythro-poietin-receptor positively regulates erythropoietin-induced cell proliferation and STAT5 activation. EMBO J 1995; 14: 5557-5568
30. Silva M, Benito A, Sanz C et al. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin dependent progenitor cell lines. J Biol Chem 1999; 274: 22165-22169
31. Damen JE, Mui AL, Puil L et al. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythro-poietin receptor. Blood 1993; 81: 3204-3210 (Pubitemid 23172900)
32. Kashii Y, Uchida M, Kirito K et al. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoi-etin signal transduction. Blood 2000; 96: 941-949 (Pubitemid 30616858)
33. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotec-tion involves cross-talk between Jak2 and NF-kappaB signaling cascades. Nature 2001; 412: 641-647 (Pubitemid 32772276)
34. Mitsuma W, Ito M, Kodama M et al. Cardioprotective effects of re-combinant human erythropoietin in rat with experimental autoimmune myocarditis. Biochem Biophys Res Commun 2006; 344: 987-994
35. Villa P, Bigini P, Mennini Tet al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003; 198: 971-975 (Pubitemid 37152934)
36. Mori S, Sawada T, Kubota K. Asialoerythropoietin is a strong modulator of angiogenesis by bone-marrow cells. J Invest Surg 2007; 20: 357-362
37. Cosyns B, Velez-Roa S, Droogmans S et al. Effects of erythropoietin administration on mitral valve regurgitation and left ventricular remodeling in heart failure patients. Int J Cardiol 2010; 138: 306-307
38. Wang X, Yao M, Zhou C et al. Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle. Neuroscience 2010; 167: 750-757